The pedigree should be evaluated to assess the AD risk, considering the consistency of family history with EOAD, LOAD, or Mendelian inheritance. Based on this information, the opportunity to perform genetic tests other than APOE should be evaluated. (Goldman et al., 2011). This evidence concerns the gene APOE and Alzheimer disease.